Compounds > ellipticine

ellipticine and vasoactive intestinal peptide

ellipticine has been researched along with vasoactive intestinal peptide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czerwinski, G; Michejda, CJ; Moody, TW; Tarasova, NI1
Czerwinski, G; Michejda, CJ; Moody, DL; Moody, TW; Tarasova, NI1

Other Studies

2 other study(ies) available for ellipticine and vasoactive intestinal peptide

ArticleYear
VIP-ellipticine derivatives inhibit the growth of breast cancer cells.
    Life sciences, 2002, Jul-19, Volume: 71, Issue:9

    Topics: Amino Acid Sequence; Breast Neoplasms; Cell Division; Ellipticines; Humans; Molecular Sequence Data; Proto-Oncogene Proteins c-fos; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Polypeptide, Type I; RNA, Messenger; Vasoactive Intestinal Peptide

2002
The development of VIP-ellipticine conjugates.
    Regulatory peptides, 2004, Dec-15, Volume: 123, Issue:1-3

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Drug Design; Ellipticines; Endocytosis; Humans; Lung Neoplasms; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Polypeptide, Type I; Thymidine; Vasoactive Intestinal Peptide

2004